TSH: What This Test Actually Measures

What TSH Is and Why It Matters

TSH is a glycoprotein hormone secreted by thyrotrope cells in the anterior pituitary gland. It acts as a chemical messenger, binding to TSH receptors on thyroid follicular cells and stimulating the production and release of thyroxine (T4) and triiodothyronine (T3) [1].

The relationship between TSH and thyroid hormones operates through a negative feedback loop. When circulating T4 and T3 levels drop, the hypothalamus releases thyrotropin-releasing hormone (TRH), which prompts the pituitary to secrete more TSH. When thyroid hormone levels rise, TSH secretion falls. This inverse logarithmic relationship means that even a modest change in free T4 concentration triggers a much larger swing in TSH. A 50% drop in free T4 can produce a 90-fold rise in TSH [2]. That amplification effect is exactly why TSH works so well as a screening tool. Small thyroid problems show up in TSH long before free T4 or T3 leave their reference ranges.

The 2012 joint statement from the American Thyroid Association and the American Association of Clinical Endocrinologists noted: "Serum TSH measurement has the best sensitivity and specificity of any single blood test used in the evaluation of suspected thyroid dysfunction" [3]. This position has not changed in subsequent guideline updates.

Normal TSH Range: Where the Lines Are Drawn

Most commercial laboratories report a reference interval of 0.4 to 4.0 mIU/L for adults, though some labs use 0.45 to 4.5 mIU/L [4]. These numbers are population-derived and come with several caveats worth understanding before you interpret your result.

Age shifts the range upward. NHANES III data (N=16,533 disease-free individuals) showed that the 97.5th percentile TSH rose from 3.56 mIU/L in the 20-to-29 age group to 5.9 mIU/L in those aged 70 to 79 [5]. An 80-year-old with a TSH of 5.2 mIU/L may be physiologically normal, while the same value in a 25-year-old warrants investigation. The Endocrine Society has recommended age-adjusted upper limits for TSH interpretation, particularly in patients over 65 [6].

Pregnancy tightens the range dramatically. First-trimester TSH drops because human chorionic gonadotropin (hCG) cross-reacts with the TSH receptor. The ATA's 2017 pregnancy guidelines recommend trimester-specific ranges derived from local assay data, or, if unavailable, a first-trimester upper limit of approximately 4.0 mIU/L rather than the previously suggested 2.5 mIU/L cutoff [7].

Race and ethnicity also matter. Black Americans have TSH values approximately 0.4 mIU/L lower than white Americans across all age groups, a finding consistent across multiple NHANES cycles [5]. Applying a single universal reference range to all populations introduces a risk of misdiagnosis.

What a High TSH Result Means

A TSH above the upper reference limit signals that the pituitary gland is working harder to push a sluggish thyroid. The degree of elevation matters.

Overt primary hypothyroidism presents with TSH above 10 mIU/L and a low free T4. Symptoms often include fatigue, weight gain, cold intolerance, constipation, and dry skin. In the Colorado Thyroid Disease Prevalence Study (N=25,862), 9.5% of participants had an elevated TSH, and those with values above 10 mIU/L had significantly higher total cholesterol and LDL levels compared to euthyroid controls [8]. Treatment with levothyroxine is recommended for all patients with TSH above 10 mIU/L per ATA guidelines [3].

Subclinical hypothyroidism describes a TSH between the upper limit (typically 4.0 to 4.5) and 10 mIU/L with a normal free T4. This is common. Prevalence in the general population runs between 4% and 10%, with higher rates in women and older adults [9]. Whether to treat subclinical hypothyroidism remains one of thyroid medicine's persistent debates. The 2019 NICE guideline recommends treatment if TSH exceeds 10 mIU/L or if the patient has symptoms and a TSH between 4.0 and 10 mIU/L, particularly in younger patients or those planning pregnancy [10].

Dr. Elizabeth Pearce, Professor of Medicine at Boston University and past president of the ATA, has stated: "The decision to treat subclinical hypothyroidism should be individualized, taking into account the degree of TSH elevation, presence of symptoms, cardiovascular risk factors, and patient preference" [11].

Other causes of elevated TSH beyond primary thyroid failure include recovery from nonthyroidal illness, TSH-secreting pituitary adenomas (rare, and TSH is usually only mildly elevated with a paradoxically high free T4), assay interference from heterophilic antibodies, and biotin supplementation, which can falsely alter TSH results on certain immunoassay platforms [12].

What a Low TSH Result Means

A TSH below 0.4 mIU/L indicates that circulating thyroid hormone is suppressing pituitary TSH output. The pituitary has detected too much T4 or T3 and has pulled back its signaling.

Overt hyperthyroidism presents with a suppressed TSH (often <0.1 mIU/L) and elevated free T4 or free T3. Graves disease accounts for 60% to 80% of hyperthyroidism cases in iodine-sufficient populations [13]. Toxic multinodular goiter and toxic adenoma make up most of the remainder. Symptoms include heat intolerance, tremor, palpitations, unintentional weight loss, anxiety, and increased bowel frequency.

Subclinical hyperthyroidism describes a TSH below 0.4 mIU/L with normal free T4 and free T3. Prevalence is roughly 2% in the general population [9]. Even mild TSH suppression carries clinical consequences. A meta-analysis published in JAMA (N=52,674) found that subclinical hyperthyroidism was associated with a 24% increase in all-cause mortality (HR 1.24, 95% CI 1.06 to 1.46) and a 29% increase in coronary heart disease mortality [14].

Exogenous thyroid hormone is the most common cause of low TSH. Patients on levothyroxine who are over-replaced will have a suppressed TSH. This is intentional in thyroid cancer survivors, where the target TSH is often 0.1 to 0.5 mIU/L depending on the risk of recurrence [15]. Outside of cancer management, iatrogenic TSH suppression increases the risk of atrial fibrillation (HR 1.68 in adults over 60) and accelerated bone loss in postmenopausal women [14].

How TSH Testing Is Performed

The test requires a standard venous blood draw. No fasting is necessary, though timing matters. TSH follows a circadian rhythm, peaking between 2:00 AM and 4:00 AM and reaching its nadir between 4:00 PM and 8:00 PM. Morning draws (before 10:00 AM) provide the most reproducible results and reduce the chance of a falsely low value obtained late in the day [16].

Modern third-generation TSH assays have a functional sensitivity of 0.01 to 0.02 mIU/L, meaning they can reliably distinguish between a mildly suppressed TSH (0.1 to 0.4 mIU/L) and a fully suppressed one (<0.01 mIU/L) [17]. This distinction is clinically meaningful because overt hyperthyroidism typically suppresses TSH below 0.01, while subclinical hyperthyroidism usually produces values in the 0.1 to 0.39 range.

Biotin interference deserves specific mention. Many patients take biotin supplements (often marketed for hair and nail health) in doses of 5 to 10 mg daily. Biotin can cause falsely low TSH on streptavidin-biotin immunoassays, mimicking hyperthyroidism. The FDA issued a safety communication in 2017 warning that biotin interference had contributed to at least one death from a falsely low troponin result [18]. Patients should stop biotin at least 48 hours before any thyroid function testing.

When to Order TSH and When It Is Not Enough

TSH is the correct first-line test for evaluating suspected thyroid dysfunction. The AACE/ATA 2012 guidelines recommend TSH as the initial test for patients presenting with symptoms of hypothyroidism or hyperthyroidism [3]. The USPSTF, however, has concluded that the evidence is insufficient to recommend screening asymptomatic, nonpregnant adults for thyroid dysfunction (I statement, 2015, reaffirmed 2023) [19].

TSH alone falls short in specific clinical scenarios. Central hypothyroidism (pituitary or hypothalamic disease) produces a low or normal TSH despite inadequate thyroid hormone levels, because the pituitary itself is damaged. Ordering free T4 alongside TSH catches this pattern. Central hypothyroidism accounts for roughly 1 in 1,000 cases of hypothyroidism [20].

Patients on medications that affect TSH independently of thyroid status also need careful interpretation. Dopamine infusions suppress TSH. Glucocorticoids suppress TSH. Metoclopramide raises TSH. Lithium can cause hypothyroidism in 20% to 30% of long-term users [21]. Amiodarone, which contains 37% iodine by weight, can cause either hypothyroidism or hyperthyroidism and should prompt a full panel (TSH, free T4, free T3) rather than TSH alone.

How to Lower or Raise TSH

TSH is not a target to manipulate directly. It is a readout. A high TSH means the thyroid is underproducing, and the treatment is thyroid hormone replacement (levothyroxine in most cases). A low TSH means thyroid hormone is excessive, and the treatment depends on the cause.

For primary hypothyroidism with elevated TSH, levothyroxine is first-line therapy. The starting dose is typically 1.6 mcg/kg/day in young, otherwise healthy patients, with lower starting doses (25 to 50 mcg/day) in older adults or those with cardiovascular disease [3]. TSH should be rechecked 6 to 8 weeks after any dose adjustment, as steady-state TSH takes approximately 5 half-lives of T4 (each half-life being 7 days) to equilibrate. Taking levothyroxine on an empty stomach, 30 to 60 minutes before breakfast, improves absorption by 70% to 80% compared to taking it with food [22].

For hyperthyroidism with suppressed TSH, management depends on the cause. Graves disease may be treated with methimazole (starting dose 10 to 30 mg/day), radioactive iodine (RAI), or thyroidectomy. The ATA's 2016 hyperthyroidism guidelines recommend methimazole as the preferred first-line drug in most patients, with a 12-to-18-month trial before considering definitive therapy [13]. Propylthiouracil (PTU) is reserved for the first trimester of pregnancy and thyroid storm.

Lifestyle factors have modest but measurable effects on thyroid function. Selenium supplementation (200 mcg/day) has been shown to reduce TPO antibody levels in Hashimoto thyroiditis, though its effect on TSH is inconsistent across trials [23]. Iodine intake must be sufficient but not excessive. The recommended daily allowance for adults is 150 mcg, increasing to 250 mcg during pregnancy [24]. Both iodine deficiency and iodine excess can raise TSH.

TSH in Pregnancy

Thyroid function testing in pregnancy is a topic that generates strong guideline recommendations. Uncontrolled maternal hypothyroidism is associated with preeclampsia, placental abruption, preterm delivery, and impaired fetal neurodevelopment [7].

The ATA's 2017 guidelines recommend trimester-specific TSH reference ranges and state that all pregnant women with known thyroid disease, a history of thyroid surgery, or type 1 diabetes should have TSH checked at pregnancy confirmation [7]. Universal screening of all pregnant women remains debated. The 2017 ATA guidelines stopped short of recommending it, though they acknowledged the argument in its favor.

For pregnant women already on levothyroxine, the dose requirement typically increases by 25% to 50% by the end of the first trimester. The ATA suggests empirically increasing levothyroxine by two extra doses per week (roughly a 30% increase) as soon as pregnancy is confirmed, with TSH monitoring every 4 weeks during the first half of pregnancy [7].

The target TSH during pregnancy, per ATA 2017 guidelines, is the lower half of the trimester-specific reference range, or below 2.5 mIU/L if population-based ranges are unavailable [7].